Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

Similar articles for PubMed (Select 23050386)

1.

Compounding prokinetic medications for companion animals.

Gaskins J.

Int J Pharm Compd. 2012 Jul-Aug;16(4):276-86. Review.

PMID:
23050386
2.

Ghrelin as a target for gastrointestinal motility disorders.

Greenwood-Van Meerveld B, Kriegsman M, Nelson R.

Peptides. 2011 Nov;32(11):2352-6. doi: 10.1016/j.peptides.2011.03.014. Epub 2011 Mar 29. Review.

PMID:
21453735
3.

Gastrointestinal motility disorders and gastrointestinal prokinetic therapy.

Washabau RJ.

Vet Clin North Am Small Anim Pract. 2003 Sep;33(5):1007-28, vi. Review.

PMID:
14552159
4.

Compounding for animal patients: contemporary issues.

Lust E.

J Am Pharm Assoc (2003). 2004 May-Jun;44(3):375-84; quiz 384-6. Review.

PMID:
15191248
5.

Extralabel drug use and compounding in veterinary medicine.

Geyer RE.

Food Drug Law J. 1997;52(3):291-5. No abstract available.

PMID:
10343027
6.

Prucalopride: a new drug for the treatment of chronic constipation.

Tack J.

Expert Rev Gastroenterol Hepatol. 2009 Aug;3(4):337-43. doi: 10.1586/egh.09.38. Review.

PMID:
19673621
7.

[Which forms of constipation could benefit from motility-active drugs?].

Müller-Lissner S.

Z Gastroenterol. 1990 Apr;28 Suppl 1:89-91; discussion 94-5. Review. German. No abstract available.

PMID:
2192511
8.

Prokinetic agents.

Reynolds JC, Putnam PE.

Gastroenterol Clin North Am. 1992 Sep;21(3):567-96. Review.

PMID:
1516959
9.

FDA seeks to clear up confusion about compounding.

[No authors listed]

J Am Vet Med Assoc. 2003 Oct 15;223(8):1103, 1106. No abstract available.

PMID:
14584731
10.

Idiopathic constipation: too few stools and too little knowledge.

Briejer MR, Schuurkes JA, Sarna SK.

Trends Pharmacol Sci. 1999 Jan;20(1):1-3. Review.

PMID:
10101952
11.

Use of prokinetic agents in special populations.

Horn JR.

Am J Health Syst Pharm. 1996 Nov 15;53(22 Suppl 3):S27-9. Review.

PMID:
8931828
12.

Access options for withdrawn motility-modifying agents.

Jones MP.

Am J Gastroenterol. 2002 Sep;97(9):2184-8. Review.

PMID:
12358230
13.

[Prokinetic agents--their contribution to practice of gastroenterology].

Hep A, Dolina J.

Vnitr Lek. 2011 Sep;57(9):693-6. Review. Czech.

PMID:
21957760
14.

New pharmacologic therapies in gastrointestinal disease.

Wallace JL, Ferraz JG.

Gastroenterol Clin North Am. 2010 Sep;39(3):709-20. doi: 10.1016/j.gtc.2010.08.020. Review.

PMID:
20951926
15.

[Gastrointestinal motility disorders and drugs: cholinergic, anticholinergic, adrenergic, antiadrenergic and prokinetic drugs (part I)].

Jovanović-Mićić D, Janković S, Beleslin DB.

Srp Arh Celok Lek. 1994 Jan-Feb;122(1-2):50-4. Review. Serbian.

PMID:
17972806
16.

[Prokinetic drugs in gastroenterology].

Galmiche JP, Bruley des Varannes S, Le Bodic L.

Gastroenterol Clin Biol. 1991;15(2 ( Pt 3)):T7-10. Review. French. No abstract available.

PMID:
2065903
17.

Prokinetic agents for lower gastrointestinal motility disorders.

Longo WE, Vernava AM 3rd.

Dis Colon Rectum. 1993 Jul;36(7):696-708. Review.

PMID:
8348856
18.

Erythromycin lacks colon prokinetic effect in children with functional gastrointestinal disorders: a retrospective study.

Venkatasubramani N, Rudolph CD, Sood MR.

BMC Gastroenterol. 2008 Aug 21;8:38. doi: 10.1186/1471-230X-8-38.

19.

Erythromycin and motilin as gastrointestinal prokinetic agents.

Asai T.

Eur J Anaesthesiol. 1997 Jan;14(1):3-6. No abstract available.

PMID:
9049551
20.

Management of chronic constipation: recommendations from a consensus panel.

Bleser S, Brunton S, Carmichael B, Olden K, Rasch R, Steege J.

J Fam Pract. 2005 Aug;54(8):691-8. Review. No abstract available.

PMID:
16061057
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk